These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31064218)

  • 21. Lipoprotein-associated phospholipase A
    Garg PK; Norby FL; Polfus LM; Boerwinkle E; Gibbs RA; Grove ML; Folsom AR; Garimella PS; Matsushita K; Hoogeveen RC; Ballantyne CM
    Atherosclerosis; 2018 Jan; 268():12-18. PubMed ID: 29169030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin autofluorescence as a measure of advanced glycation end products deposition predicts 5-year amputation in patients with peripheral artery disease.
    de Vos LC; Boersema J; Mulder DJ; Smit AJ; Zeebregts CJ; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1532-7. PubMed ID: 25882066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
    Ding N; Kwak L; Ballew SH; Jaar B; Hoogeveen RC; Ballantyne CM; Sharrett AR; Folsom AR; Heiss G; Salameh M; Coresh J; Hirsch AT; Selvin E; Matsushita K
    Atherosclerosis; 2018 Jul; 274():86-93. PubMed ID: 29753232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Appiah D; Schreiner PJ; MacLehose RF; Folsom AR
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2700-6. PubMed ID: 26494231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults.
    Semba RD; Arab L; Sun K; Nicklett EJ; Ferrucci L
    J Nutr; 2011 Sep; 141(9):1726-30. PubMed ID: 21775524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating levels of carboxy‐methyl‐lysine (CML) are associated with hip fracture risk: the Cardiovascular Health Study.
    Barzilay JI; Bůžková P; Zieman SJ; Kizer JR; Djoussé L; Ix JH; Tracy RP; Siscovick DS; Cauley JA; Mukamal KJ
    J Bone Miner Res; 2014; 29(5):1061-6. PubMed ID: 24877243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrosis-related biomarkers and large and small vessel disease: the Cardiovascular Health Study.
    Agarwal I; Arnold A; Glazer NL; Barasch E; Djousse L; Fitzpatrick AL; Gottdiener JS; Ix JH; Jensen RA; Kizer JR; Rimm EB; Siscovick DS; Tracy RP; Wong TY; Mukamal KJ
    Atherosclerosis; 2015 Apr; 239(2):539-46. PubMed ID: 25725316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triglyceride-glucose index in the development of peripheral artery disease: findings from the Atherosclerosis Risk in Communities (ARIC) Study.
    Gao JW; Hao QY; Gao M; Zhang K; Li XZ; Wang JF; Vuitton DA; Zhang SL; Liu PM
    Cardiovasc Diabetol; 2021 Jun; 20(1):126. PubMed ID: 34167539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study.
    de la Cruz-Ares S; Cardelo MP; Gutiérrez-Mariscal FM; Torres-Peña JD; García-Rios A; Katsiki N; Malagón MM; López-Miranda J; Pérez-Martínez P; Yubero-Serrano EM
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.
    Nin JW; Jorsal A; Ferreira I; Schalkwijk CG; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
    Diabetes Care; 2011 Feb; 34(2):442-7. PubMed ID: 21270199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study.
    Semba RD; Bandinelli S; Sun K; Guralnik JM; Ferrucci L
    Eur J Appl Physiol; 2010 Jan; 108(1):191-5. PubMed ID: 19756703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women.
    Semba RD; Ferrucci L; Fink JC; Sun K; Beck J; Dalal M; Guralnik JM; Fried LP
    Am J Kidney Dis; 2009 Jan; 53(1):51-8. PubMed ID: 18789567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Circulating Hepatocyte Growth Factor and Risk of Incident Peripheral Artery Disease: The Multi-Ethnic Study of Atherosclerosis.
    Garg PK; Buzkova P; Wassell CL; Allison M; Criqui M; Larson NB; Bielinski SJ
    Angiology; 2020 Jul; 71(6):544-551. PubMed ID: 32202143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol mass efflux capacity and risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis.
    Garg PK; Jorgensen NW; McClelland RL; Allison M; Stein JH; Yvan-Chavret L; Tall AR; Shea S
    Atherosclerosis; 2020 Mar; 297():81-86. PubMed ID: 32097805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of a dominant advanced glycation end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: the Baltimore Longitudinal Study of Aging.
    Semba RD; Beck J; Sun K; Egan JM; Carlson OD; Varadhan R; Ferrucci L
    J Nutr Health Aging; 2010 Aug; 14(7):507-13. PubMed ID: 20818463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Life's Simple 7 and Peripheral Artery Disease: The Multi-Ethnic Study of Atherosclerosis.
    Unkart JT; Allison MA; Criqui MH; McDermott MM; Wood AC; Folsom AR; Lloyd-Jones D; Rasmussen-Torvik LJ; Allen N; Burke G; Szklo M; Cushman M; McClelland RL; Wassel CL
    Am J Prev Med; 2019 Feb; 56(2):262-270. PubMed ID: 30553692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
    Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
    Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple biomarkers for mortality prediction in peripheral arterial disease.
    Amrock SM; Weitzman M
    Vasc Med; 2016 Apr; 21(2):105-12. PubMed ID: 26762418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GlycA, a Novel Inflammatory Marker and Its Association With Peripheral Arterial Disease and Carotid Plaque: The Multi-Ethnic Study of Atherosclerosis.
    Fashanu OE; Oyenuga AO; Zhao D; Tibuakuu M; Mora S; Otvos JD; Stein JH; Michos ED
    Angiology; 2019 Sep; 70(8):737-746. PubMed ID: 31030528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients.
    Sotomayor CG; Gomes-Neto AW; van Londen M; Gans ROB; Nolte IM; Berger SP; Navis GJ; Rodrigo R; Leuvenink HGD; Schalkwijk CG; Bakker SJL
    Clin J Am Soc Nephrol; 2019 Oct; 14(10):1512-1520. PubMed ID: 31530552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.